Cubist Pharmaceuticals
E1476313
UNEXPLORED
Cubist Pharmaceuticals was a biopharmaceutical company best known for developing and commercializing antibiotics to treat serious and drug-resistant infections.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Cubist Pharmaceuticals canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T21289787 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Cubist Pharmaceuticals Context triple: [Paul Schimmel, coFounded, Cubist Pharmaceuticals]
-
A.
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for thrombosis and other hematologic conditions.
-
B.
Millennium Pharmaceuticals
Millennium Pharmaceuticals is a biotechnology company known for developing innovative cancer therapies, including the proteasome inhibitor bortezomib (Velcade) for multiple myeloma.
-
C.
Mapp Biopharmaceutical
Mapp Biopharmaceutical is a U.S.-based biotechnology company best known for developing antibody-based therapies for infectious diseases, including experimental treatments for Ebola.
-
D.
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a biopharmaceutical company specializing in developing and commercializing innovative medicines for sleep disorders, oncology, and rare diseases.
-
E.
Cubic Corporation
Cubic Corporation is a technology-driven defense and transportation solutions company known for providing fare collection systems, training, and mission support services to governments and transit agencies worldwide.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Cubist Pharmaceuticals Target entity description: Cubist Pharmaceuticals was a biopharmaceutical company best known for developing and commercializing antibiotics to treat serious and drug-resistant infections.
-
A.
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for thrombosis and other hematologic conditions.
-
B.
Millennium Pharmaceuticals
Millennium Pharmaceuticals is a biotechnology company known for developing innovative cancer therapies, including the proteasome inhibitor bortezomib (Velcade) for multiple myeloma.
-
C.
Mapp Biopharmaceutical
Mapp Biopharmaceutical is a U.S.-based biotechnology company best known for developing antibody-based therapies for infectious diseases, including experimental treatments for Ebola.
-
D.
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a biopharmaceutical company specializing in developing and commercializing innovative medicines for sleep disorders, oncology, and rare diseases.
-
E.
Cubic Corporation
Cubic Corporation is a technology-driven defense and transportation solutions company known for providing fare collection systems, training, and mission support services to governments and transit agencies worldwide.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.